GLPwatch
Trials (2101)
Page 28 of 36.
- A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
- ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
- Effect of Semaglutide in Patients With Psoriasis and Obesity
- Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
- Study of Patients Being Treated With Anti-obesity Medication
- A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss
- Risk Factors Affect Weight Loss Outcomes After Treatment.
- Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
- Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
- Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
- Semaglutide vs Sitagliptin
- Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
- Retrospective Analysis for Patients With Metabolic Syndrome
- The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
- a Study of JY09 in Chinese Healthy Subjects
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
- A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
- A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
- Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
- Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study
- A Study of Dulaglutide in Healthy Participants
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
- Semaglutide Treatment in Type 1 Diabetes
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
- Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
- Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors